Tvardi Therapeutics Inc.
TVRD | NASDAQ
$1.59
-$0.02 (-1.24%)
Sep 22, 2026, 3:01 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 15.77M | 19.85M | 20.73M | 21.42M | 20.65M | 11.44M | 37.9M | 38.56M | 49.24M | 47M | 22.92M | 63.28M |
Short-Term Investments | n/a | 5.13M | 10.08M | 15.04M | 20.35M | 10.87M | n/a | 4.98M | 7.38M | 22.78M | n/a | 15.67M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.5M | 1.5M | 1.5M | 6.25M |
Other Long-Term Assets | 17K | 17K | 17K | 17K | 17K | 3.71M | n/a | n/a | n/a | n/a | -1.48M | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | 4.5M | 1.37M | 1.82M | 2.92M | 4.02M | 5.73M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | 900K | 625K | 1.64M | 2.74M | n/a | 3.27M |
Other Current Assets | n/a | 345K | n/a | 1.98M | n/a | n/a | n/a | n/a | n/a | n/a | -4.02M | n/a |
Total Current Assets | 17.07M | 25.33M | 31.54M | 38.44M | 43.13M | 23.46M | 43.83M | 47.91M | 63.86M | 81.23M | 26.16M | 100.6M |
Property-Plant & Equipment | 140K | 168K | 196K | 223K | 249K | 275K | n/a | 3.42M | 7.14M | 7.37M | 378K | 8.49M |
Goodwill & Intangibles | 291K | 306K | 322K | 338K | 354K | 369K | n/a | n/a | n/a | n/a | 448K | n/a |
Total Long-Term Assets | 448K | 491K | 535K | 578K | 620K | 4.35M | n/a | 3.42M | 8.64M | 8.87M | 843K | 14.74M |
Total Assets | 17.52M | 25.82M | 32.07M | 39.02M | 43.75M | 27.81M | 43.83M | 51.33M | 72.5M | 90.1M | 27M | 115.34M |
Account Payables | 4.64M | 4.62M | 3.22M | 4.08M | 2.43M | 1.69M | 1.43M | 2.54M | 6.76M | 4.98M | 1.61M | 7.98M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.42M | 168K | 220K | n/a | 497K |
Other Current Liabilities | n/a | 729K | 1.3M | 1.01M | 7.4M | n/a | 1.97M | 2.91M | 5.76M | 7.83M | 942K | 9.04M |
Total Current Liabilities | 9.11M | 11.26M | 11.04M | 11.04M | 10.68M | 7M | 3.97M | 10.04M | 13.9M | 15.1M | 3.28M | 22.88M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | 35.76M | 44.45M | 40.58M | 39.68M | 38.38M | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 85.5M | n/a |
Total Long-Term Liabilities | 22K | 54K | 85K | 115K | 145K | 35.93M | 44.45M | 40.58M | 47M | 45.2M | 85.78M | 6.82M |
Total Liabilities | 9.14M | 11.31M | 11.13M | 11.16M | 10.82M | 42.93M | 48.42M | 50.62M | 60.9M | 60.3M | 89.06M | 29.7M |
Total Debt | 145K | 174K | 201K | 228K | 254K | 36.04M | 44.45M | 44M | 47.16M | 45.42M | 368K | 7.31M |
Book Value | 8.38M | 14.51M | 20.95M | 27.87M | 32.93M | -15.12M | -4.59M | 707K | 11.6M | 29.8M | -62.06M | 85.64M |
Book Value Per Share | 0.89 | 1.55 | 2.23 | 2.97 | 3.89 | -1.62 | -3.01 | 0.46 | 7.63 | 3.19 | -6.63 | 56.85 |
Common Stock | 9K | 9K | 9K | 9K | 9K | 19K | 5K | 54K | 54K | 54K | 19K | 54K |
Retained Earnings | -123.71M | -117.25M | -110.45M | -103.18M | -97.65M | -101.82M | -755.61M | -747.93M | -735.46M | -715.44M | -62.84M | -652.41M |
Comprehensive Income | n/a | 1K | 8K | 7K | -13K | 2K | n/a | -25K | -121K | -191K | n/a | -439K |
Shareholders Equity | 8.38M | 14.51M | 20.95M | 27.87M | 32.93M | -15.12M | -4.59M | 707K | 11.6M | 29.8M | -62.06M | 85.64M |
Total Investments | n/a | 5.13M | 10.08M | 15.04M | 20.35M | 10.87M | n/a | 4.98M | 8.88M | 24.28M | 1.5M | 21.91M |
Add to Watchlist
Select watchlists to add or remove TVRD